ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,08165
0,00%
Bitcoin
69.487,39
0,22%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Generation Bio Company (GBIO)

  7. Generation Bio Company (GBIO) News

GBIO

Generation Bio (GBIO)

Generation Bio Company
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:GBIO
DatumZeitQuelleÜberschriftSymbolFirma
07/06/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
13/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
13/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
13/05/202422h05GlobeNewswire Inc.Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
09/05/202412h59GlobeNewswire Inc.Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
22/04/202423h31GlobeNewswire Inc.Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
02/04/202412h59GlobeNewswire Inc.Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
06/03/202422h38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GBIOGeneration Bio Company
06/03/202422h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GBIOGeneration Bio Company
06/03/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
06/03/202422h20GlobeNewswire Inc.Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:GBIOGeneration Bio Company
27/02/202412h59GlobeNewswire Inc.Generation Bio to Present at the 2024 TD Cowen Health Care ConferenceNASDAQ:GBIOGeneration Bio Company
02/02/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
31/01/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
31/01/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
17/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
17/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
17/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
17/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
17/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
17/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
08/01/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
03/01/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
03/01/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
03/01/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
03/01/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
03/01/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
03/01/202422h05GlobeNewswire Inc.Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
11/12/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
06/12/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
 Showing the most relevant articles for your search:NASDAQ:GBIO

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
TG
ALV
Allianz
TG
BAYN
Bayer
FX
EURUSD
Euro vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
DBI
MDAX
MDAX
AMEX
XLV
Health Care Select Sector
TG
NOV
Novo Nordisk
NASDAQ
AMZN
Amazon.com
TG
TUI1
Tui
NYSE
KO
Coca Cola
NASDAQ
TSLA
Tesla
DBI
SDXP
SDAX
CCOM
US500
US 500
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten